Avestar Capital’s GSK GSK Stock Holding History

Avestar Capital’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,052	Closed	-$50K	–	440
2019 Q2	$50K	Buy	1,052 +2	+0.2%	+$100	0.03%	289
2019 Q1	$53K	Buy	1,050 +694	+195%	+$34.7K	0.03%	278
2018 Q4	$14K	Sell	356 -304	-46%	-$15K	0.01%	383
2018 Q3	$31K	Buy	660 +341	+107%	+$17.3K	0.02%	316
2018 Q2	$14K	Buy	319 +74	+30%	+$3.73K	0.01%	407
2018 Q1	$9K	Sell	245 -295	-55%	-$13.7K	0.01%	442
2017 Q4	$21K	Buy	+540	New	+$24.9K	0.02%	333

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Avestar Capital's GSK Position: Q3 2019 in Review

Avestar Capital sold out of GSK (GSK) in Q3 2019, closing a stake of 1,052 shares — an estimated $50K sold.

Avestar Capital first reported a position in GSK in Q4 2017 and held it in 7 quarters. The position peaked at $53K in Q1 2019. 805 funds tracked by Wall St. Rank hold GSK as of Q3 2019.

Avestar Capital reported no remaining GSK position as of Q3 2019 after selling out during the quarter.
Avestar Capital sold 1,052 GSK shares in Q3 2019, an estimated $50K.
Avestar Capital first reported a position in GSK in Q4 2017 and held it in 7 quarters.
Avestar Capital's GSK position peaked at $53K in Q1 2019.
805 funds tracked by Wall St. Rank held GSK as of Q3 2019.

Based on Avestar Capital's 13F filing for Q3 2019, filed 14 Nov 2019.